Last reviewed · How we verify
Standard medical treatment
Standard medical treatment involves the administration of a standard medical treatment to restore normal health.
Standard medical treatment involves the administration of a standard medical treatment to restore normal health. Used for General medical conditions.
At a glance
| Generic name | Standard medical treatment |
|---|---|
| Also known as | Aspirin, Clopidogrel, standard treatment, unilateral laparoscopic adrenalectomy, transmetil, compound glycyrrhizinate, reduced glutathione and hepatocyte growth factor, et. al., Aspirin, clopidogrel, anticoagulant |
| Sponsor | Beijing Tiantan Hospital |
| Drug class | Standard medical treatment |
| Modality | Small molecule |
| Therapeutic area | General Medicine |
| Phase | FDA-approved |
Mechanism of action
Standard medical treatment is a well-established approach that aims to alleviate symptoms and prevent complications. It is based on evidence-based guidelines and expert consensus. The treatment is tailored to the individual's specific needs and medical history.
Approved indications
- General medical conditions
Common side effects
- None reported
Key clinical trials
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A) (PHASE2)
- Bedside Bike Early Mobilization Program for Inpatients (NA)
- Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer (PHASE2)
- Ablation Versus Medical Management of Atrial Fibrillation in HFpEF (NA)
- Perioperative Telemonitoring to Optimize Cancer Care and Outcomes (NA)
- Exercise for the Treatment of Cancer-Related Sarcopenia (NA)
- Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard medical treatment CI brief — competitive landscape report
- Standard medical treatment updates RSS · CI watch RSS
- Beijing Tiantan Hospital portfolio CI